Evaluation of IL-2, IL-10, IL-17 and IP-10 as potent discriminative markers for active tuberculosis among pulmonary tuberculosis suspects
Author:
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),Immunology,Microbiology
Reference44 articles.
1. Tuberculosis. Genenva;World Health Organiztion,2013
2. New approaches in the diagnosis and treatment of latent tuberculosis infection;Ahmad;Respir Res,2010
3. Interferon-gamma release assays versus tuberculin skin testing for the diagnosis of latent tuberculosis infection: an overview of the evidence;Trajman;Pulm Med,2013
4. Potential role of M. tuberculosis specific IFN-γ and IL-2 ELISPOT assays in discriminating children with active or latent tuberculosis;Chiappini;PLoS One,2012
5. Detection of interleukin-2 in addition to interferon-gamma discriminates active tuberculosis patients, latently infected individuals, and controls;Biselli;ClinMicrobiol Infect.,2010
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Therapeutic Drug Monitoring and Biomarkers; towards Better Dosing of Antimicrobial Therapy;Pharmaceutics;2024-05-17
2. Importance of IP-10 as a biomarker of host immune response: Critical perspective as a target for biosensing;Current Research in Biotechnology;2023
3. Evaluation of tuberculosis diagnostic biomarkers in immunocompromised hosts based on cytokine levels in QuantiFERON-TB Gold Plus;Tuberculosis;2022-09
4. Challenges and Future of Drug-Induced Liver Injury Research—Laboratory Tests;International Journal of Molecular Sciences;2022-05-27
5. A peptide-based vaccine ACP derived from antigens of Mycobacterium tuberculosis induced Th1 response but failed to enhance the protective efficacy of BCG in mice;Indian Journal of Tuberculosis;2021-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3